China Shineway Pharmaceutical Group Limited (CSWYF) Financial Statements
$1.00OTC: CSWYFMarket Cap $758.42M
China Shineway Pharmaceutical Group Limited most recently reported annual revenue of $3.1B, net profit of $950.0M, revenue has compounded at 4.5% a year over the last five years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.